Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zomedica's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.37M. For fiscal 2025 it was -$17.65M. The highest annual figure on record is -$4.56M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.65M | – |
| FY2024 | Dec 31, 2024 | -$23.63M | – |
| FY2023 | Dec 31, 2023 | -$15.98M | – |
| FY2022 | Dec 31, 2022 | -$11.67M | – |
| FY2021 | Dec 31, 2021 | -$14.28M | – |
| FY2020 | Dec 31, 2020 | -$16.24M | – |
| FY2019 | Dec 31, 2019 | -$15.63M | – |
| FY2018 | Dec 31, 2018 | -$11.15M | – |
| FY2017 | Dec 31, 2017 | -$7.09M | – |
| FY2016 | Dec 31, 2016 | -$4.56M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.26M | – |
| Q4 FY2025 | Dec 31, 2025 | -$899.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.66M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.65M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.59M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.02M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.03M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.68M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.05M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.47M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.00M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.74M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.68M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.66M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.72M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.17M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.87M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.91M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.58M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.33M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.37M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.74M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.71M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.98M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.44M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.11M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.55M | – |
See a number that looks wrong?